Costa Saroukos
- Business
Takeda’s Growth and Emerging Markets Business Unit Aims to Deliver Double-Digit Revenue Growth Over Next Decade1
Osaka, Japan & Cambridge, Mass., United States: Aiming for Revenues of JPY 1 Trillion (approximately US$9 Billion2) by FY2030 Double-Digit…
Read More » - Business
Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited
Osaka, Japan: sset transfer furthers Takeda’s global strategy to focus on five key business areas Takeda will continue to manufacture…
Read More »